急性冠状动脉综合征患者血浆sRAGE、IFN-γ浓度及其与冠状动脉病变严重程度的关系

doi:10.3969/j.issn.1006-7795.2023.02.014

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (2): 272-279.doi: 10.3969/j.issn.1006-7795.2023.02.014

急性冠状动脉综合征患者血浆sRAGE、IFN-γ浓度及其与冠状动脉病变严重程度的关系

罗晓萌¹，江雪²，杜凤和³，郭彩霞^2*

1.北京积水潭医院急诊科，北京 100035； 2.首都医科大学附属北京同仁医院心血管中心，北京 100030; 3.首都医科大学附属北京天坛医院老年科，北京 100070

收稿日期:2022-05-26 出版日期:2023-04-21 发布日期:2023-04-18
通讯作者: 郭彩霞 E-mail:cxgbb@ 163. com
基金资助:
国家自然科学基金(81570321）

Levels of sRAGE and IFN-γ in the plasma of patients with acute coronary syndrome and their relationship with the severity of coronary artery lesions

Luo Xiaomeng¹， Jiang Xue²， Du Fenghe³, Guo Caixia^2*

1.Department of Emergency, Beijing Jishuitan Hospital, Capital Medical University, Beijing 100035, China; 2. Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100030, China； 3.Department of Geriatrics, Beijing Tiantan Hospital， Capital Medical University, Beijing 100070, China

Received:2022-05-26 Online:2023-04-21 Published:2023-04-18
Supported by:
This study was supported by National Natural Science Foundation of China(81570321）

摘要/Abstract

摘要： 目的探讨不同类型急性冠状动脉综合征患者血浆中可溶性晚期糖基化终末产物受体(soluble receptor for advanced glycation end product，sRAGE)、γ-干扰素(interferon-γ，IFN-γ) 浓度及其与冠状动脉病变严重程度的关系。方法纳入2016年6月至2018年6月于首都医科大学附属北京天坛医院行冠状动脉造影的236例患者，分为急性心肌梗死组(n=42)、不稳定型心绞痛组(n=119)、非冠状动脉粥样硬化性心脏病(以下简称冠心病）组(n=75）。用酶联免疫法检测各组血浆中sRAGE 和 IFN-γ浓度并比较。分别分析急性心肌梗死患者、不稳定型心绞痛患者sRAGE、 IFN-γ在不同Gensini评分分组中的差异及其与冠状动脉病变支数的相关性。分析急性心肌梗死患者sRAGE、 IFN-γ与心肌梗死标志物心肌肌钙蛋白(cardiac troponin I，cTnI）、肌红蛋白(myoglobin，Myo）、肌酸激酶同工酶(creatine kinase isoenzyme，CK-MB）的相关性。结果急性心肌梗死组患者 sRAGE 浓度最高，非冠心病组最低。急性心肌梗死组 IFN-γ 浓度高于不稳定型心绞痛组和非冠心病组，不稳定型心绞痛组和非冠心病组差异无统计学意义。多因素 Logistics 回归分析显示 sRAGE浓度升高是急性心肌梗死和不稳定型心绞痛的独立危险因素，且与急性心肌梗死的关系更为密切。急性心肌梗死患者血浆中sRAGE与 IFN-γ浓度呈正相关，两者均与心肌梗死标志物cTnI、Myo、CK-MB呈正相关，与Gensini评分、冠状动脉病变支数未见明显相关性。不稳定型心绞痛患者，高Gensini组sRAGE及IFN-γ浓度大于中Gensini组和低Gensini组， sRAGE浓度以三支病变组最高、单支病变组最低， IFN-γ浓度以双支病变组最高、单支病变组最低。结论急性冠状动脉综合征患者血浆中sRAGE浓度明显升高，并且急性心肌梗死者高于不稳定型心绞痛患者。不稳定型心绞痛患者中sRAGE及IFN-γ浓度与冠状动脉病变严重程度呈正相关。

关键词: 急性冠状动脉综合征, 急性心肌梗死, 不稳定型心绞痛, 可溶性晚期糖基化终末产物受体, γ-干扰素

Abstract: Objective To investigate the plasma levels of soluble receptor for advanced glycation end product (sRAGE) and interferon-γ (IFN-γ) in patients with different types of acute coronary syndromes and their relationship with the severity of coronary artery lesions. Methods A total of 236 patients who underwent coronary angiography in Beijing Tiantan Hospital, Capital Medical University from June 2016 to June 2018 were included and divided into acute myocardial infarction group (n=42), unstable angina pectoris group (n=119), non-(coronary heart disease, CHD) group (n=75). The levels of sRAGE and IFN-γ in the plasma of each group were detected and compared by enzyme-linked immunosorbent assay. The differences of sRAGE and IFN-γ in patients with acute myocardial infarction and unstable angina pectoris in different Gensini score groups and their correlation with the number of coronary artery lesions were analyzed， respectively. The correlations between sRAGE and IFN-γ and myocardial infarction markers cardiac troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) in patients with acute myocardial infarction were analyzed. Results The sRAGE level was the highest in the acute myocardial infarction group and the lowest in the non-coronary heart disease group. The level of IFN-γ in the acute myocardial infarction group was higher than that in the unstable angina pectoris group and the non-coronary heart disease group, and there was no significant difference between the unstable angina pectoris group and the non-coronary heart disease group. Multivariate Logistic regression analysis showed that elevated sRAGE level was an independent risk factor for acute myocardial infarction and unstable angina, and was more closely related to acute myocardial infarction. In patients with acute myocardial infarction, sRAGE and IFN-γ were positively correlated, and both were positively correlated with myocardial infarction markers cTnI, Myo, and CK-MB, but had no significant correlation with Gensini score and the number of coronary artery lesions. In unstable angina pectoris, the levels of sRAGE and IFN-γ in the high GS group were higher than those in the medium Gensini group and the low Gensini group. The sRAGE level was the highest in the three-vessel disease group and the lowest in the single-vessel disease group, and the IFN-γ level was the highest in the double-vessel disease group and the lowest in the single-vessel disease group. Conclusion The level of sRAGE in the plasma of patients with acute coronary syndrome is significantly increased, and the level of sRAGE in patients with acute myocardial infarction is higher than that in patients with unstable angina pectoris. The levels of sRAGE and IFN-γ in unstable angina pectoris were positively correlated with the severity of coronary artery disease.

Key words: acute coronary syndrome, acute myocardial infarction, unstable angina pectoris, soluble receptor for advanced glycation end-products (sRAGE), γ-interferon (IFN-γ)

中图分类号:

R541

罗晓萌, 江雪, 杜凤和, 郭彩霞. 急性冠状动脉综合征患者血浆sRAGE、IFN-γ浓度及其与冠状动脉病变严重程度的关系[J]. 首都医科大学学报, 2023, 44(2): 272-279.

Luo Xiaomeng, Jiang Xue, Du Fenghe, Guo Caixia. Levels of sRAGE and IFN-γ in the plasma of patients with acute coronary syndrome and their relationship with the severity of coronary artery lesions[J]. Journal of Capital Medical University, 2023, 44(2): 272-279.

参考文献

［1］Hudson B I, Lippman M E. Targeting RAGE signaling in inflammatory disease［J］. Annu Rev Med, 2018, 69: 349－364.
［2］Woniak M, Konopka C J, Poska A, et al. Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease［J］. Cell Mol Biol Lett, 2021, 26(1):10.
［3］Ghosh S, Kapoor D, Vijayvergiya R, et al. Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women［J］. World J Cardiol, 2021, 13(5):130－143.
［4］Cai X Y, Lu L, Wang Y N, et al. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury［J］. Atherosclerosis, 2011, 217(2):536－542.
［5］Jensen L J N, Lindberg S, Hoffmann S, et al. Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patients［J］. Clin Biochem, 2015, 48(4/5):297－301.
［6］Elyasi A, Voloshyna I, Ahmed S, et al. The role of interferon-γ in cardiovascular disease: an update［J］. Inflamm Res, 2020, 69(10):975－988.
［7］Whitman S C, Ravisankar P, Daugherty A. IFN-γ deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E－/－ mice［J］. J Interferon Cytokine Res, 2002, 22(6):661－670.
［8］Zhao Z, Wu Y, Cheng M L, et al. Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome［J］. Atherosclerosis, 2011, 217(2):518－524.
［9］Brisslert M, Amu S, Pullerits R. Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19+, CD3+ and Mac-1+ cells in lymphoid organs and peritoneal cavity［J］. Cell Tissue Res, 2013, 351(1):139－148.
［10］Zhang X L, Cao X X, Dang M Q, et al. Soluble receptor for advanced glycation end-products enhanced the production of IFN-γ through the NF-κB pathway in macrophages recruited by ischemia/reperfusion［J］. Int J Mol Med, 2019, 43(6):2507－2515.
［11］Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease［J］. Am J Cardiol, 1983, 51(3):606.
［12］朱馨媛, 郭彩霞, 张立克, 等. 血浆内源性sRAGE、esRAGE、cRAGE对冠心病及其并发急性心肌梗死的诊断价值［J］. 临床心血管病杂志, 2010, 26(7):517－520.
［13］Larsen H G, Yndigegn T, Marinkovic G, et al. The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event［J］. Atherosclerosis, 2019, 287: 16－23.
［14］Lindsey J B, De Lemos J A, Cipollone F, et al. Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study［J］. Diabetes Care, 2009, 32(7):1218－1220.
［15］Liu W J, Ji Y Q, Zhang W W, et al. Correlation analysis of CML, sRAGE, and esRAGE and the measure of atherosclerosis of coronary heart disease［J］. Comput Intell Neurosci, 2022, 2022: 8970860.
［16］Wang X M, Xu T T, Mungun D, et al. The relationship between plasma soluble receptor for advanced glycation end products and coronary artery disease［J］. Dis Markers, 2019, 2019: 4528382.
［17］Prasad K, Khan A S, Bhanumathy K K. Does AGE-RAGE stress play a role in the development of coronary artery disease in obesity?［J］. Int J Angiol, 2022, 31(1):1－9.
［18］McNair E D, Wells C R, Qureshi A M, et al. Inverse association between cardiac troponin-I and soluble receptor for advanced glycation end products in patients with non-ST-segment elevation myocardial infarction［J］. Int J Angiol, 2011, 20(1):49－54.
［19］Prasad K. AGE-RAGE stress and coronary artery disease［J］. Int J Angiol, 2021, 30(1):4－14.
［20］Nazari-Jahantigh M, Wei Y Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages［J］. J Clin Invest, 2012, 122(11):4190－4202.
［21］Scott R A, Panitch A. Decorin mimic regulates platelet-derived growth factor and interferon-γ stimulation of vascular smooth muscle cells［J］. Biomacromolecules, 2014, 15(6):2090－2103.
［22］Weng X Y, Cheng X, Wu X Y, et al. Sin3B mediates collagen type I gene repression by interferon gamma in vascular smooth muscle cells［J］. Biochem Biophys Res Commun, 2014, 447(2):263－270.
［23］Libby P. Inflammation in atherosclerosis［J］. Arterioscler Thromb Vasc Biol, 2012, 32(9):2045－2051.
［24］Akamatsu Y, Yamamoto T, Yamamoto K, et al. Porphyromonas gingivalis induces myocarditis and/or myocardial infarction in mice and IL-17A is involved in pathogenesis of these diseases［J］. Arch Oral Biol, 2011, 56(11):1290－1298.
［25］Wang H L, Zhang N, Li G R, et al. Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease［J］. Life Sci, 2019, 231: 116510.
［26］Yang Z C, Shi L, Xue Y, et al. Interleukin-32 increases in coronary arteries and plasma from patients with coronary artery disease［J］. Clin Chim Acta, 2019, 497: 104－109.
［27］Karnosová P, Mateánková M, Seidlerová J, et al. Soluble RAGEs and cardiovascular risk factors in adult offspring of patients with premature coronary heart disease［J］. Blood Press, 2020, 29(2):87－94.
［28］Dang M Q, Zeng X J, Chen B X, et al. Interferon-γ mediates the protective effects of soluble receptor for advanced glycation end-product in myocardial ischemia/reperfusion［J］. Lab Invest, 2019, 99(3):358－370.

急性冠状动脉综合征患者血浆sRAGE、IFN-γ浓度及其与冠状动脉病变严重程度的关系

Levels of sRAGE and IFN-γ in the plasma of patients with acute coronary syndrome and their relationship with the severity of coronary artery lesions

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价